A recent article by American Council on Science and Health Senior Medical Fellow Charles Dinerstein highlights a recent lawsuit filed be three pharmaceutical companies fighting the Trump administration's mandate which requires drugmakers to include a drug's list price in television ads. Amgen, […]
Drugmakers Suing Trump White House Over Ad Mandate
Drugmakers Amgen, Merck and Eli Lilly are suing the Trump administration over its recent rule requiring pharmaceutical companies to include a drug's list price in television ads, STAT reports. The Association of National Advertisers is also involved in the lawsuit, according to the report. Amgen […]
FTI Consulting Working with Pfizer on Drug Pricing
FTI Consulting is reportedly working with pharmaceutical giant Pfizer on drug pricing matters, according to a Consulting.us report. Few details were provided in the report regarding the scope of the arrangement. Pfizer is one of 20 organizations involved in a massive lawsuit led by Connecticut […]
WHO Signs Off on Drug Pricing Resolution
The World Health Organization (WHO) on Tuesday, May 28, gave the green light to a draft resolution that signals member countries are preparing to push for more transparency in drug pricing, Reuters reports. According to the report, the resolution approved did not include rules requiring […]
Novartis’ Zolgensma About to Hit Market with Record Price Tag
Novartis' new gene therapy for the treatment of spinal muscular atrophy (SMA) is soon to hit the market with an expected price of roughly $2 million, the Wall Street Journal reports. While the drugmaker has not yet set the price of Zolgensma, according to the report, executives say the health […]
Podcast Outlines Potential Implications of Rebate Proposal for Pharma
A recent Relentless Health Value podcast spotlights what could be in store for the pharmaceutical industry as the Department of Health and Human Services continues to work on its proposal to eliminate rebate payments to pharmacy benefit managers. The podcast features Kuo Tong, managing director of […]
Pharma Giants Join Blockchain Platform
Several major pharmaceutical companies have joined the MediLedger Project, a blockchain-powered platform aimed at addressing inefficiencies in the current supply chain, BlockPublisher reports. According to the report, Pfizer, McKesson, Amerisource Bergen Corporation and Premier Inc. have signed on […]
Activists Flock to PhRMA HQ
Some 200 activists on Monday, April 29, took to the streets outside PhRMA's Washington headquarters to protest the trade association's alleged role in blocking "Medicare for All," STAT reports. The protesters later made their way through the building's entrance, according to the report, plastering […]
Article: RWE Can Better Inform Policy Decisions
Real-world evidence (RWE) offers an "exciting opportunity" for drugmakers to make more informed decisions using robust data sets, McKesson's Sarah Alwardt writes in an article published on the American Journal of Managed Care. Recent guidance by the Food and Drug Administration (FDA), Alwardt […]
Hospitals, Insurers Eye Drug Rebate Rule
Insurers and hospitals say the Centers for Medicare and Medicaid Services (CMS) should include in a recently-proposed rule some new requirements for pharmaceutical companies, Modern Healthcare reports. Organizations in response to the rule suggested that eliminating safe harbor for Medicare Part D […]
